MAYNE PHARMA GROUP LIMITED — Director's Dealing 2012

Feb 16, 2012

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	MAYNE PHARMA GROUP LIMITED
ABN	76 115 832 963

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	DR ROGER ASTON
Date of last notice	30 May 2011
Date that director ceased to be director	15 February 2012

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

3,820,000 Ordinary Shares

625,000 Unlisted options for ordinary shares @ 60 cents expiring 17 April 2012 1,900,000 Unlisted options for ordinary shares @ 27 cents expiring 31 December 2012

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

==> picture [401 x 140] intentionally omitted <==

----- Start of picture text -----

Name of holder & nature of Number & class of securities
interest
Note: Provide details of the circumstances giving rise to
the relevant interest
4,251,000 Ordinary Shares
Newtonmore Biosciences Pty Ltd
1,000,000 Ordinary Shares
Newtonmore Super Fund
----- End of picture text -----

Part 3 – Director’s interests in contracts

==> picture [406 x 155] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
No. and class of securities to N/A
which interest relates
----- End of picture text -----

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 2